candesartan has been researched along with 2019 Novel Coronavirus Disease in 4 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elkahloun, AG | 1 |
| Saavedra, JM | 1 |
| Pedrosa, MA | 1 |
| Valenzuela, R | 1 |
| Garrido-Gil, P | 1 |
| Labandeira, CM | 1 |
| Navarro, G | 1 |
| Franco, R | 1 |
| Labandeira-Garcia, JL | 1 |
| Rodriguez-Perez, AI | 1 |
| Simko, F | 1 |
| Baka, T | 1 |
| Lukito, AA | 1 |
| Widysanto, A | 1 |
| Lemuel, TAY | 1 |
| Prasetya, IB | 1 |
| Massie, B | 1 |
| Yuniarti, M | 1 |
| Lumbuun, N | 1 |
| Pranata, R | 1 |
| Meidy, C | 1 |
| Wahjoepramono, EJ | 1 |
| Yusuf, I | 1 |
4 other studies available for candesartan and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Candesartan could ameliorate the COVID-19 cytokine storm.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Betacoronavirus; Biphenyl Compounds; Bronch | 2020 |
Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19.
Topics: ADAM17 Protein; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensi | 2021 |
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; | 2021 |
Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study.
Topics: Benzimidazoles; Biphenyl Compounds; COVID-19; Humans; Prospective Studies; SARS-CoV-2; Tetrazoles; T | 2021 |